Editorial board

EDITOR-IN-CHIEF

Carol Lange, PhD, University of Minnesota

 

ENDOCRINE TUMORS

Tobias Else*, MD, University of Michigan

Guillaue Assie, MD, PhD, Inst. National de la Santé et de la Recherche Médicale

Eric Baudin, MD, PhD, Gustave Roussy Institute

Graeme Eisenhofer, PhD, Technical University of Dresden

Martin Fassnacht, University of Wuerzburg

Lauren M. Fishbein, MD, University of Pennsylvania

• Research focus: Neuroendocrine tumors, pheochromocytoma and paraganglioma, cancer genetics, hereditary cancer syndromes, metastasis

 

Manisha Shah, MD, Ohio State University

 

THYROID TUMORS

Rebecca E. Schweppe, PhD, University of Colorado

Sheue-yann Cheng, PhD, National Cancer Institute

Paul J. Davis, MD, Albany Medical College

Julie Ann Sosa, MD, Duke University

Sissy Jhiang, PhD, Ohio State University

• Research focus: Thyroid cancer, sodium iodide symporter, radiosensitivity, racial disparity, SPECT/CT imaging

Aime Franco, PhD, Children's Hospital of Philadelphia

• Research focus: Thyroid cancer, pediatric thyroid disease, signal transduction, transgenic mouse models, tumor microenvironment

Carmelo Nucera, MD, PhD, Harvard University

• Research focus: Thyroid cancer, BRAFV600E and mouse models, tumor microenvironment, thyroid cancer and drug resistance, LincRNA, translational models of thyroid cancers

 

"OMICS" APPROACHES TO UNDERSTANDING CANCER, BIOINFORMATICS, BIOSTATISTICS

Dinny Graham, PhD, University of Sydney

Siyuan Zheng, PhD, UT Health Science Center San Antonio

• Research focus: Adrenal cancer, brain cancer, bioinformatics, cancer genomics, telomeres, and telomerase

Arun Sreekumarm, PhD, Baylor College of Medicine

Hari Singhal, PhD, Roche Molecular Systems

• Research focus: Computational biology, bioinformatics, cancer immunotherapy, hormonal signaling, machine learning

Alpay Temiz, PhD, University of Minnesota

Dexiang Gao, PhD, University of Colorado

 

PROSTATE CANCER

Scott M. Dehm, PhD, University of Minnesota

Nancy L. Weigel, PhD, Baylor College of Medicine

Andrea Morandi, PhD, University of Florence

Steven P. Balk, MD, PhD, Beth Isreal Deaconess Medical Center

Gail S. Prins, PhD, University of Illinois

• Research focus: Prostate cancer, estrogen signaling, estrogen receptors, androgen receptors, stem cells

Shuk-mei Ho, PhD, University of Cincinnati

Gail P. Risbridger, PhD, Monash University

Ganesh Raj, MD, PhD, University of Texas

Kathleen Torkko, PhD, University of Colorado

 

BREAST CANCER

Jennifer K. Richer*, PhD, University of Colorado

Jason Carroll, PhD, Cancer Research UK Cambridge Institute

Patricia V. Elizalde, PhD, IBYME, CONICET

Jonna Frasor, PhD, University of Illinois

Matthew P. Goetz, MD, Mayo Clinic

Ellis R. Levin, MD, University of California, Irvine

Leigh C. Murphy, PhD, University of Manitoba

Steffi Oesterreich, PhD, University of Pittsburgh

Carol A. Sartorius, PhD, University of Colorado

Haihua Gu, PhD, Wenzhou Medical University

• Research focus: Breast cancer, metastasis, signal transduction, targeted therapy, drug resistance

Dorraya El-Ashry, PhD, Breast Cancer Research Foundation, Masonic Cancer Center, University of Minnesota

• Research focus: Breast cancer, tumor microenvironment, metastasis, signal transduction, estrogen receptor

Naoto Uenu, MD, PhD, MD Anderson Cancer Center

 

GYNECOLOGIC ONCOLOGY

Seema Khan*, MD, Northwestern University

Radhika Gogoi, MD, PhD, Geisinger Medical Center

Shannon Hawkins, MD, PhD, Indiana University

Kimberly K. Leslie, MD, University of Iowa

Carlos Telleria, PhD, McGill University

• Research focus: Gynecologic-related cancer, ovarian cancer pathogenesis and therapy

Joanna Burdette, PhD, University of Illinois

 

*Associate Editors